Cigna Transforms Care Experience for Patients With Complex Conditions With Launch of Full Spectrum, Cost-Saving Products

Rhea-AI Summary

Cigna has launched Cigna Pathwell, a suite of health products aimed at improving care for patients with high-cost conditions. Integrating Evernorth's analytics with Cigna's medical benefits, Pathwell targets biologic medicines and musculoskeletal pain, enhancing the healthcare experience for patients and their employers. The initiative promises cost reduction and personalized support, especially for those needing infusion therapies. The Pathwell suite aims to evolve further in 2023, adapting to emerging health trends.

Positive

• Launch of Cigna Pathwell suite to improve patient care and reduce healthcare costs.
• Integration with Evernorth's analytics for enhanced patient support.
• Focus on biologic medicines, addressing a significant portion of drug spending (65%).
• Pathwell addresses key healthcare spending drivers, including musculoskeletal pain.
• Future expansion of services aimed at improving health outcomes.

Negative

• None.

• The concierge service from Cigna Pathwell creates a personalized end-to-end health journey for each patient and streamlines benefits management for their employer
• Pathwell integrates Cigna's high-performing provider networks and medical benefits management with Evernorth's analytics, clinical expertise, and personalized digital support

BLOOMFIELD, Conn., Sept. 28, 2022 /PRNewswire/ -- Cigna (NYSE:CI), a global health service company, unveiled Cigna Pathwell, a new, industry-leading suite of products that connects customers with quality care providers to help improve health outcomes and lower costs for customers, their families, and their employers. Cigna Pathwell harnesses the analytics, clinical expertise, treatment planning, and personalized digital solutions within Evernorth, Cigna's health services business, and integrates them with Cigna's medical benefits management and high-performing provider networks to create a comprehensive and personalized care experience for patients living with high-cost health conditions.

The Cigna Pathwell suite is launching with products to address two of the biggest drivers of health care spending: infused or injectable biologic medicines and musculoskeletal pain. Pathwell will continue to expand to address emerging health trends.

"Our clients and customers are exhausted by the fragmented health care system. They want one place to go to get a personalized experience for their entire health care journey," said Heather Dlugolenski, senior vice president, U.S. solutions, Cigna. "Cigna Pathwell connects customers with the providers and therapies that are best suited to their unique health conditions and – through our unparalleled data and expertise – can help anticipate their future needs to help them recover faster. For employers, Cigna Pathwell means lower costs, less time communicating between different tools, and streamlined benefits management for high-cost, intensive conditions, so they can focus more of their time on what matters most: their business and their workforce."

Pathwell Specialty^SM supports patients with complex or rare conditions

Cigna Pathwell Specialty^SM works within the medical and pharmacy benefits to coordinate and drive down the cost of care, both for patients who need infusions or injectable medicines and for their health plans.

Patients in enrolled plans receive concierge service from Pathwell Specialty's dedicated care management team to connect them to convenient, quality, and affordable options for infusion therapies through Cigna's national Pathwell network of quality providers. The patient's treating physician continues to oversee their care, and the patient can receive infusions from participating hospitals, infusion centers, physicians' offices, or, in some cases, at home. Alternatively, treating providers can order specialty infused or injected medications directly through a specialty pharmacy in the Cigna Pathwell Specialty network.

"Biologic medicines can be life-changing for patients, but only if they can afford them," said Dr. Ajani Nimmagadda, chief medical officer, Cigna Pharmacy. "These innovative therapies account for 65% of drug spending, even though only 4% of Cigna customers need them. Cigna Pathwell Specialty leverages the unique expertise across Cigna and Evernorth to drive down the total cost of care for patients and their plans and ensures that these patients navigating complex health conditions have the personalized support they need to thrive."

Over time, Cigna Pathwell Specialty will expand to include additional care services to support patients using infused or injected therapies throughout their health journey, including behavioral, wellness, and nutritional services, and virtual visits with doctors. It will also include support and resources for patients' caregivers through the Cigna Caregiver Bridge Program.

Addressing musculoskeletal conditions through Pathwell Bone & Joint^SM

A recent study from the Evernorth Research Institute found that nearly one in four people seek care for "wear and tear" musculoskeletal conditions such as strains and sprains, and that these conditions drive significantly higher health care spending – accounting for nearly two-thirds of all musculoskeletal care utilization and spend. 

Pathwell Bone & Joint^SM combines Cigna's national network of quality providers, personalized benefit designs, programs with whole-person support, access to behavioral health care, and physical therapy (digitally or in-person). Cigna's capabilities, combined with Evernorth's digital navigation tools and advanced predictive analytics that can anticipate a surgery up to a year in advance, create a holistic, integrated musculoskeletal solution that will improve health outcomes while reducing unnecessary surgeries that can lead to increased costs. If surgery is necessary, Cigna's benefit provides support with low or zero cost for surgery from admission through discharge. The Evernorth study also found that musculoskeletal spend can be reduced up to 40% with appropriate interventions and better-coordinated care – which is what Pathwell is designed to provide.

The Cigna Pathwell suite of solutions is available to many U.S. commercial clients, and its availability will be expanded throughout 2023. The suite will continue to evolve based on this flexible blueprint for innovation to support the needs of health plans and patients navigating a range of complex health conditions. 

About Cigna

Cigna Corporation is a global health service company dedicated to improving the health, well-being, and peace of mind of those we serve. Cigna delivers choice, predictability, affordability, and access to quality care through integrated capabilities and connected, personalized solutions that advance whole person health. All products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, Connecticut General Life Insurance Company, Evernorth companies or their affiliates, and Express Scripts companies or their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy, vision, supplemental benefits, and other related products.

Cigna maintains sales capability in over 30 countries and jurisdictions, and has over 190 million customer relationships around the world. To learn more about Cigna^®, including links to follow us on Facebook or Twitter, visit www.cigna.com.

Media Contact

Meaghan MacDonald
1 (860) 840-1212
meaghan.macdonald@cigna.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cigna-transforms-care-experience-for-patients-with-complex-conditions-with-launch-of-full-spectrum-cost-saving-products-301634904.html

SOURCE Cigna

FAQ

What is Cigna Pathwell and its purpose?

Cigna Pathwell is a suite of health products designed to improve care for patients with high-cost health conditions, integrating analytics and medical benefits management.

How does Cigna Pathwell help patients with biologic medicines?

Cigna Pathwell Specialty supports patients needing infusions or injectable medicines, providing concierge service and connections to affordable care options.

When was Cigna Pathwell launched?

Cigna Pathwell was launched on September 28, 2022.

What conditions does Cigna Pathwell address?

Cigna Pathwell initially targets biologic medicines and musculoskeletal pain.

How does Cigna Pathwell benefit employers?

Cigna Pathwell offers lower costs and streamlined benefits management for employers dealing with high-cost health conditions.